NLM Logo

lifitegrast MeSH Supplementary Concept Data 2021


MeSH Supplementary
lifitegrast
Unique ID
C575157
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C575157
Entry Term(s)
(2S)-2-(((2-(benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6- yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid
L-phenylalanine, n-((2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl)-3-(methylsulfonyl)-
SAR 1118
SAR-1118
SHP-606
SHP606
Xiidra
lifitegrast ophthalmic solution
Pharm Action
Ophthalmic Solutions
Registry Number
038E5L962W
Heading Mapped to
Phenylalanine / *analogs & derivatives
*Sulfones
Frequency
35
Note
An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES.
Source
J Ocul Pharmacol Ther. 2011 Feb;27(1):99-104.
Indexing Information
Lymphocyte Function-Associated Antigen-1
Date of Entry
2012/09/25
Revision Date
2019/10/30
lifitegrast Preferred
Xiidra Narrower
SHP-606 Narrower
lifitegrast ophthalmic solution Related
SAR 1118 Narrower
page delivered in 0.005s